chrX-120455550-G-C
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_002294.3(LAMP2):āc.204C>Gā(p.Asp68Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000415 in 1,203,493 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002294.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAMP2 | NM_002294.3 | c.204C>G | p.Asp68Glu | missense_variant | 3/9 | ENST00000200639.9 | NP_002285.1 | |
LAMP2 | NM_001122606.1 | c.204C>G | p.Asp68Glu | missense_variant | 3/9 | NP_001116078.1 | ||
LAMP2 | NM_013995.2 | c.204C>G | p.Asp68Glu | missense_variant | 3/9 | NP_054701.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMP2 | ENST00000200639.9 | c.204C>G | p.Asp68Glu | missense_variant | 3/9 | 1 | NM_002294.3 | ENSP00000200639.4 | ||
LAMP2 | ENST00000434600.6 | c.204C>G | p.Asp68Glu | missense_variant | 3/9 | 1 | ENSP00000408411.2 | |||
LAMP2 | ENST00000371335.4 | c.204C>G | p.Asp68Glu | missense_variant | 3/9 | 1 | ENSP00000360386.4 | |||
LAMP2 | ENST00000706600.1 | c.204C>G | p.Asp68Glu | missense_variant | 3/9 | ENSP00000516464.1 |
Frequencies
GnomAD3 genomes AF: 0.0000271 AC: 3AN: 110890Hom.: 0 Cov.: 20 AF XY: 0.00 AC XY: 0AN XY: 33088
GnomAD3 exomes AF: 0.00000545 AC: 1AN: 183343Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67799
GnomAD4 exome AF: 0.00000183 AC: 2AN: 1092603Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 358067
GnomAD4 genome AF: 0.0000271 AC: 3AN: 110890Hom.: 0 Cov.: 20 AF XY: 0.00 AC XY: 0AN XY: 33088
ClinVar
Submissions by phenotype
Danon disease Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 11, 2022 | Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This sequence change replaces aspartic acid, which is acidic and polar, with glutamic acid, which is acidic and polar, at codon 68 of the LAMP2 protein (p.Asp68Glu). This variant is present in population databases (rs376215728, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with LAMP2-related conditions. ClinVar contains an entry for this variant (Variation ID: 379589). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 24, 2022 | The p.D68E variant (also known as c.204C>G), located in coding exon 3 of the LAMP2 gene, results from a C to G substitution at nucleotide position 204. The aspartic acid at codon 68 is replaced by glutamic acid, an amino acid with highly similar properties. Based on data from gnomAD, the G allele has an overall frequency of <0.01% (1/183343) total alleles studied, with no hemizygotes observed. The highest observed frequency was <0.01% (1/13158) of African alleles. This amino acid position is not well conserved in available vertebrate species, and glutamic acid is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 05, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at